- Filed
- May 6, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 127.81M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 129.49M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2025 | 135.33M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2025 | 137.94M sh |
| Dividends Paid | Q3 2026 · Mar 31, 2026 | $157.77M |
| Dividends Paid | Q3 2026 · Mar 31, 2025 | $147.14M |
| Capex | Q3 2026 · Mar 31, 2026 | $67.14M |
| Capex | Q3 2026 · Mar 31, 2025 | $71.78M |
| Operating Cash Flow | Q3 2026 · Mar 31, 2026 | $586.72M |
| Operating Cash Flow | Q3 2026 · Mar 31, 2025 | $429.32M |
| Long Term Debt | Q3 2026 · Mar 31, 2026 | $1.49B |
| Long Term Debt | Q3 2026 · Jun 30, 2025 | $1.14B |
| Cash And Equivalents | Q3 2026 · Mar 31, 2026 | $867.01M |
| Cash And Equivalents | Q3 2026 · Jun 30, 2025 | $983.28M |
| Stockholders Equity | Q3 2026 · Mar 31, 2026 | −$24.37M |
| Stockholders Equity | Q3 2026 · Dec 31, 2025 | −$823.08M |
| Stockholders Equity | Q3 2026 · Sep 30, 2025 | −$550.91M |
| Stockholders Equity | Q3 2026 · Jun 30, 2025 | $88.9M |
| Stockholders Equity | Q3 2026 · Mar 31, 2025 | −$192.84M |
| Stockholders Equity | Q3 2026 · Dec 31, 2024 | −$872.46M |
| Stockholders Equity | Q3 2026 · Sep 30, 2024 | −$368.07M |
| Stockholders Equity | Q3 2026 · Jun 30, 2024 | $90.59M |
| Current Liabilities | Q3 2026 · Mar 31, 2026 | $1.29B |
| Current Liabilities | Q3 2026 · Jun 30, 2025 | $1.3B |
| Total Liabilities | Q3 2026 · Mar 31, 2026 | $3.42B |
| Total Liabilities | Q3 2026 · Jun 30, 2025 | $3.18B |
| Current Assets | Q3 2026 · Mar 31, 2026 | $1.29B |
| Current Assets | Q3 2026 · Jun 30, 2025 | $1.16B |
| Total Assets | Q3 2026 · Mar 31, 2026 | $3.39B |
| Total Assets | Q3 2026 · Jun 30, 2025 | $3.26B |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | $6.60 |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | $3.38 |
| Eps Diluted | Q3 2026 · Mar 31, 2025 | $5.31 |
| Eps Diluted restated | Q3 2026 · Mar 31, 2021 | $2.21 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | $6.66 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | $3.41 |
| Eps Basic | Q3 2026 · Mar 31, 2025 | $5.37 |
| Eps Basic | Q3 2026 · Mar 31, 2025 | $2.24 |
| Sga Expense | Q3 2026 · Mar 31, 2026 | $329.33M |
| Sga Expense | Q3 2026 · Mar 31, 2026 | $623.72M |
| Sga Expense | Q3 2026 · Mar 31, 2025 | $329.4M |
| Sga Expense | Q3 2026 · Mar 31, 2025 | $640.11M |
| Net Income | Q3 2026 · Mar 31, 2026 | $847.9M |
| Net Income | Q3 2026 · Mar 31, 2026 | $439.92M |
| Net Income | Q3 2026 · Dec 31, 2025 | −$242.17M |
| Net Income | Q3 2026 · Sep 30, 2025 | −$165.82M |
| Net Income | Q3 2026 · Mar 31, 2025 | $722.33M |
| Net Income | Q3 2026 · Mar 31, 2025 | $306.33M |
| Net Income | Q3 2026 · Dec 31, 2024 | −$243.42M |
| Net Income | Q3 2026 · Sep 30, 2024 | −$172.58M |
| Cost Of Revenue | Q3 2026 · Mar 31, 2026 | $1.03B |
| Cost Of Revenue | Q3 2026 · Mar 31, 2026 | $1.65B |
| Cost Of Revenue | Q3 2026 · Mar 31, 2025 | $969.39M |
| Cost Of Revenue | Q3 2026 · Mar 31, 2025 | $1.55B |
| Revenue | Q3 2026 · Mar 31, 2026 | $2.4B |
| Revenue | Q3 2026 · Mar 31, 2026 | $2.8B |
| Revenue | Q3 2026 · Mar 31, 2025 | $2.28B |
| Revenue | Q3 2026 · Mar 31, 2025 | $2.65B |
| Shares Outstanding | Q3 2026 · Jan 30, 2026 | 126.76M sh |